Amgen Stock Stable Despite Bad News Tied to Drug

Nov 7, 2009
 

BIOTECH: Aranesp generates poor test results and a federal lawsuit. Los Angeles Business Journal Staff Aranesp once looked like Amgen Inc.’s supernova, predicted to turn into another blockbuster product for the Thousand Oaks... [read full story]                    

powered by
Add Comment
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies